Search Results 331-340 of 18200 for Immunode

1. A Study to Evaluate the Use of Nivolumab and Pomalidomide Combination for Relapsed/Refractory Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma - Mayo Clinic

   Immunodeficiency states including human immunodeficiency virus (HIV) infection. Active hepatitis B or C with uncontrolled disease. NOTE: a detailed ...

2. A Study to Evaluate the Safety and Effectiveness of APT-1011 to Treat Eosinophilic Esophagitis - Mayo Clinic

   Immunosuppression or immunodeficiency disorder. Current malignancy or malignancy within 3 years of Screening. Subjects in remission for at least 3 years ...

3. A Study of ALX148 With Azacitidine for Higher Risk Myelodysplastic Syndrome - Mayo Clinic

   Known active viral infections, including hepatitis B and C, human immunodeficiency virus (HIV), acquired immunodeficiency syndrome (AIDS) related illness, or ...

4. Study to Evaluate the Safety and Effectiveness of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Relapsed/Refractory Large B-cell Lymphoma - Mayo Clinic

   Primary immunodeficiency; History of autoimmune disease (e.g., Crohn's, rheumatoid arthritis, systemic lupus) resulting in end organ injury or requiring ...

5. Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) - Mayo Clinic

   Known history of human immunodeficiency virus (HIV) infection. Hepatitis B (HBV) or C (HCV) infection. Patients positive for hepatitis B surface antigen ...

6. Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P Mutation - Mayo Clinic

   Has a positive test for human immunodeficiency virus (HIV-1 or -2) hepatitis C virus (HCV) or hepatitis B surface antigen (HBsAg); Receiving chronic systemic ...

7. A Study of the Effect of Vedolizumab in Conjunction with Structured Semi-Vegetarian Diet on the Treatment of Ulcerative Colitis - Mayo Clinic

   Human immunodeficiency virus; Immunodeficiency syndrome; Untreated tuberculosis; History of central nervous system demyelinating disease; History of malignancy ...

8. Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer - Mayo Clinic

   No patients with immunodeficiency or receiving Nivolumab equivalent to > 10 mg prednisone per day or any other form of immunosuppressive therapy within 7 ...

9. A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Anti-N-Methyl-D-Aspartic Acid Receptor (NMDAR) Or Anti-Leucine-Rich Glioma-Inactivated 1 (LGI1) Encephalitis (Cielo) - Mayo Clinic

   * Congenital or acquired immunodeficiency, including HIV infection * Active or presence of recurrent bacterial, viral, fungal, mycobacterial infection, or ...

10. A Study to Evaluate the Safety and Effectiveness of BMS-986036 (pegbelfermin) in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Fibrosis - Mayo Clinic

    ... immunodeficiency virus, or who have recurrent or chronic systemic bacterial, fungal, viral or protozoal infections; Major episode of infection requiring ...